Anal cancer prevention in people living with HIV

This seminar will include presentations from two research studies focussing on anal cancer.

Professor Joel Palefsky (Professor of Medicine and Infectious Diseases at the University of California San Francisco School of Medicine, United States) will present the ANal Cancer/HSIL Outcomes Research study (ANCHOR) results and their implications. ANCHOR was a randomised study designed to answer whether treatment of anal cancer precursors prevents anal cancer among persons living with HIV. 

Dr Mary Poynten (Senior Research Fellow, HIV Epidemiology and Prevention Program, Kirby Institute) will talk about the Study of the Prevention of Anal Cancer, a study of the natural history of anal HPV and associated disease in HIV-negative and HIV-positive gay and bisexual men provides data that can inform the development of anal cancer screening programs in Australia.

*Please note this is a hybrid seminar with registration options for in-house attendance and livestream.

Check out theevent page for speaker bios and latest updates: https://kirby.unsw.edu.au/event/professor-joel-palefsky-dr-mary-poynten-anal-cancer-prevention-people-living-hiv

Image credit: NCI Center for Cancer Research